|
|
Article: New Data Indicate That the Antiviral 'Substance R' May Enhance AIDS Cocktail Therapy; Dr. Hirschman of Advanced Viral Research Corp. Presents Findings at Conference.
- Article from:
- Business Wire
- Article date:
- November 17, 1999
CopyrightCOPYRIGHT 1999 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MCLEAN, Va.--(BW HealthWire)--Nov. 17, 1999--
Shalom Z. Hirschman, M.D., President and CEO of Advanced Viral Research Corp. (OTCBB:ADVR), reported yesterday that the experimental drug, Substance R (Reticulose(TM)), appears to "turn on" the body's beneficial response to fight viral infections, including HIV (human immunodeficiency virus) and HPV (human papilloma virus). Advanced Viral Research Corp. is developing Substance R, a non-toxic peptide-nucleic acid, as a broad spectrum antiviral drug.
Speaking at a Cambridge HealthTech Institute conference on chemokines and chemokine receptors -- proteins that play an important role in trafficking immune system ...